《藥學(xué)英語》教學(xué)課件 unit 8_第1頁
《藥學(xué)英語》教學(xué)課件 unit 8_第2頁
《藥學(xué)英語》教學(xué)課件 unit 8_第3頁
《藥學(xué)英語》教學(xué)課件 unit 8_第4頁
《藥學(xué)英語》教學(xué)課件 unit 8_第5頁
已閱讀5頁,還剩71頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

§11Others

§11Others

一、Thecontentsofothers1、Characteristics:包括藥物的藥理作用特點(diǎn)、療效、劑量及藥物代謝。eg1:①patent:專利(CA.中有專利索引patentindex)②non-narcoticnon—

非--否定詞前綴一、Thecontentsofothers1、ChProperties:eg2:①抗代謝的anti-metabolism②葉酸folicacidFH4四氫葉酸③腫瘤tumor④化療chemotherapy/

放療radiotherapyeg3:①本品毒性小,副作用極為輕微Toxicityislow,Sideeffectsareminimal.②臨床效果:clinicaleffecteg4:①抗炎作用:anti-inflammatoryProperties:Pharmacokinetics:include:metabolism、absorption、distributionandelimination.

*eg7:英漢互譯,要求學(xué)生掌握其中的六個(gè)專業(yè)術(shù)語Theabsolutebioavailabilityofthedrugim.Orsc.Isapproximately70%.Itpeakplasmaconcentrationisattainedwithinonehourandithashalf-lifeofeliminationof70-90minutes.Upto95%ofthedoseisexcretedviathekidneys,2%asunchangeddrug,.Theapparentvolumeofdistributeis0.15-0.31/kgandprotainbinding30-40%.Pharmacokinetics:4overdosage:includetheeffect,signsandsympotoms,treatmentofoverdosage.5interactionordruginteraction詞綴:inter相互eachothereg11:Temariltabletsshouldnotbeadministratedwith4hoursofmedicationscontainingMgnesium,aluminium,orironsaltsasinterferencewithabsorptionmyoccur.eg12:Simultaneousconsumptionofalcoholcanimpairreactiontime,egintrafficorduringreactionofmachines.Athigherdosageofthedrugwithsimultaneousadministrationofbloodpressureloweringmedicamentstheeffectofthelattercanbepotentiated.4overdosage:6ValidityValiditystoragelifeExp.dateshelflifeStableStability:activitytoxicityeg15:Exp:18months(Expirydateisprintedontheviallabel.)6Validity二、otherterms1、參考文獻(xiàn):reference:refer(v.)=literature學(xué)習(xí)書寫論文的一般格式:論文標(biāo)題/摘要/關(guān)鍵詞/參考文獻(xiàn)

title/abstract/keywords/reference2、臨床數(shù)據(jù):clinicaldata=clinicaleffect3、耐受性:tolerance----tolerate

耐藥性:resistance----resistant4、批號:BatchNo.5、制造:madeinmanufacture二、otherterms1、參考文獻(xiàn):reference實(shí)驗(yàn)研究型論文(一)內(nèi)容結(jié)構(gòu)1、中文標(biāo)題2、作者3、中文摘要、關(guān)鍵詞(3—5個(gè))4、正文:

(1)引言

(2)材料與方法

(3)結(jié)果與數(shù)據(jù)處理

(4)討論

(5)結(jié)論

5、參考文獻(xiàn)實(shí)驗(yàn)研究型論文(一)內(nèi)容結(jié)構(gòu)HPLC測定小兒清肺止咳泡騰片中黃芩苷的含量

XXX

(浙江醫(yī)藥高等??茖W(xué)校,浙江寧波315100)

摘要:目的:建立一種用高效液相色譜法測定小兒清肺止咳泡騰片中黃芩苷含量的方法。方法:高效液相色譜柱為:DiamonsilC18柱(5μm,250mm×4.6mm);流動相:甲醇-水-甲酸(50︰50︰0.2);檢測波長:280nm;流速:1.2ml/min;結(jié)果:黃芩苷在17.2~172μg/ml的范圍內(nèi)與峰面積呈良好的線性關(guān)系。平均回收率97.97%;RSD為2.18%。結(jié)論:該方法快速,準(zhǔn)確,專屬性好,靈敏度高,可用于小兒清肺止咳泡騰片中黃芩苷的含量測定。關(guān)鍵詞:高效液相色譜法;黃芩苷;小兒清肺止咳泡騰片;含量測定HPLC測定小兒清肺止咳泡騰片中黃芩苷的含量

XXX

(浙DeterminationofBaicalininXiaoerQingfeiZhike

EffervescentTabletbyHPLC

Abstract:Objective:ToestablishacontentdeterminationmethodofbaicalininXiao’erQingfeiZhikeEffervescentTabletbyHPLC.Methods:Results:Conclusion:Keywords:HPLC;Baicalin;XiaoerQingfeiZhikeEffervescentTablet;AssayDeterminationofBaicalinin文獻(xiàn)綜述型畢業(yè)論文1、中文標(biāo)題2、作者3、中文摘要、關(guān)鍵詞(3—5個(gè))4、正文:

(1)引言

(2)正文主要內(nèi)容

(3)展望5、參考文獻(xiàn)文獻(xiàn)綜述型畢業(yè)論文1、中文標(biāo)題三、生產(chǎn)廠家的表示方法:制藥廠:Pharmaceuticalfactory制藥有限公司:pharmaceuticalCO.,Ltd制藥股份有限公司:pharmaceuticalInc.(Incorperator)三、生產(chǎn)廠家的表示方法:制藥廠:Pharmaceutica四、homework按照標(biāo)準(zhǔn)格式,書寫“Aspirin”英文藥品說明書。

ThestructureofEgnlishpackageinsert[Drugname]:[Tradename][Genericname][Chemicalname][Description]:[Pharmacologicalaction]:[Indication]:[Contraindication]:[DosageandAdministration]:[AdverseReaction]:[Precaution]:[Storage]:[Package]:[Others]:[BatchNo.]

[Validity][manufacture]四、homework§1Angised§1Angised[Drugname]:

[tradename]:Angised

(心絞痛Angina)

[genericname]:glyceryltrinitrate

說明:(gly—甘油--yl基團(tuán)

tri—三--ate酸或酯,此處為酯)

[chemicalname]:glyceryltrinitrate[Drugname]:[Description]:

Eachwhite,round,flat,uncoatedtabletsisscoredandimpressed說明:“WellcomP2A”andcontains500microgramsglycerylforsublingualadministration.Analysis:①color:white②shape:roundandflat③preparation:uncoatedandscoredtablet④indigrents:500mgglyceryltrinitrate⑤administration:sl.[Description]:[Pharmacologicalaction]:

①Angisedredistributesbloodflow②Angisedalsoreducedoxygendemand

③ThefallinarterialpressurewillalsoreducemyocardialO2demand.(ItcanreducemyocardialO2demand.)

④Reductionofpreload.

詞綴:pre---dosthbeforeeg.preview預(yù)習(xí)

re---dosthagainoraftereg.review復(fù)習(xí)[Pharmacologicalaction]:[Indication]:(1)acuteattacksofanginapectoris

(2)fortheprophylaxisofsuchattack

(3)pulmonaryoedema[Contra-indication]:

anginacausedbyhypertrophicobstructivecardiomyopathy.

詞綴:myo---肌肉

cerebralhaemorrhageorheadtrauma

詞綴:ha(e)mo---血[Indication]:[DosageandAdministration]:(1)Administration:sublingual

(2)Dosage:

require:Treatmentofacuteattacks①Onetabletshouldbegivenevery3minite.②Theminimumeffectivedose.③Patientsshouldkeepsittingposition《藥學(xué)英語》教學(xué)課件unit8[Adversereaction]:

largedosagemayresultinvomiting,cyanosis,restlessness,impairmentofrespiration,methaemoglobinaemia.[Precaution]:

①②③④⑤[Adversereaction]:[Storage]:

below25℃.Protectfromlight[Package]:

①inglasscontainers②closedwithafoil-linedcap③nocotton-wool[Storage]:[Others]:

[pharmacokinetics]:

1、WhyndoesnotAngisedbetakenbyorally?Glyceryitrinitrateisreadilyabsorbedinthebuccalmucosabutisrapidlymetabolized.ItisalsoreadilyabsorbedinG-Itractbutowingtotheextensivefirst-passmetabolismintheliver.It’sbioavailabilityisreduced.[Others]:2、hydrolysisprocess:

glyceryltrinitrate----glyceryldinitrate----glycerylmononitrate3、metabolismtime:peakplasmalevelappearswithin4minuteatleasthalfoftheintact(untouched、unchanged)drugisclearedfromthebloodin1—3minute.2、hydrolysisprocess:[Druginteraction]:

TherisksofhypotensionandsyncopewithuseofAngisedmaybeebhancedbytheeffectsofalcohol.[Overdosage]:

Methaemoglobinaemiamaybetreatedbyiv.methyleneblue.

(詞綴:methyl---甲基;---ene烯烴)[BatchNo.]:略

[validity]:3years[manufacture]:WellcomFoundationLtdLondon.[Druginteraction]:*§2Temaril

*§2Temaril一、Thebackgroudof“--xacin”

喹啉羧酸類:

①Norfloxacin:85年上市

②Ciprofloxacin:Temaril③Pefloxacin:④Lomefloxacin:⑤Sparfloxacin:⑥Ofloxacin:Terivid一、Thebackgroudof“--xacin”喹TheinformationsaboutCiprofloxacin[Drugname]:

[Tradename]:Temaril[Genericname]:Ciprofloxacin

環(huán)丙沙星

[Chemicalname]:略TheinformationsaboutCiprofl[Description]:

①Infusion:

Temaril:100,clear,almostcolorlesstopaleyellowsilutioncontaining127.2mgCiprofloxacinlactate(equivalentto100mgCiprofloxacin)in50mlsolution.②Tablet:

Temaril:250,white,scored,film-coatedtabletsmarkedononesidewith250,eachtabletscontaining291.5mgCiprofloxacinhydrochloridemonohydrate.Question:WhyCiprofloxacinInfusion---lactateTablet---hydrochloride[Description]:[Pharmacologicalaction]:

①Thedrugisasynthetic(TCM.extract),4-quinolonederivativewithbactericidalactivityagainstawiderangeofG+andG-.(Points:Terms:bactericidalactivity/widerange)②Thedrugisindicatedforthetreatmentofsingleinfectionsormixedinfectionscausedbytwoormoresusceptibleorganisms.(Points:Drill:---beindicatedforthetreatment---)Terms:singleinfectionmixedinfectionsusceptibleorganisms[Pharmacologicalaction]:③Itmaybeusedforinfectionscausedbyorganismsresistanttootherantibiotics,including:aminoglycoside,penicillin

(β-lactam)andcephalosporins.Points:氨基糖苷aminoglycoside

盤尼西林(青霉素)penicillinβ-內(nèi)酰胺β-lactam

頭孢菌素cephalosporins

耐藥性resistant③Itmaybeusedforinf[Microbiologic]:(略)常見致病菌名稱,以后工作中遇到作為資料查閱.[Indication]:

①seversystemicinfection②Respiratorytractinfection③Ear,noseandthroatinfections④Urinarytractinfectionsskinandsofttissueinfection[Microbiologic]:(略)[Contraindication]:[DosageandAdministration]:

Administration:OrallyorInfusionaccordingtothedifferentdosageformDosagerange:foradultis250-750mgtwicedaily.[Adversereaction]:[Precaution]:[Storage][Package]:[Others]:[BatchNo.]:

[validity]:

[manufacture]:作業(yè):請按照教材自己補(bǔ)充完全。[Contraindication]:Temaril【藥品名稱】:【商品名稱】:替馬利爾【通用名稱】:環(huán)丙沙星【性狀】:本品為白色有刻痕的薄膜片。

【藥理作用】:本品是一種合成的4-喹喏酮的衍生物,對廣泛的G+和G-具有殺菌作用。【適應(yīng)癥】:本品適用于治療由敏感細(xì)菌引起的下列感染。

《藥學(xué)英語》教學(xué)課件unit8【禁忌癥】:對本品以及其他喹喏酮類藥物過敏的患者忌用?!緞┝亢陀梅ā浚撼扇藙┝糠秶鸀?00~200mg,每日兩次。【不良反應(yīng)】:本品一般耐受良好,最常報(bào)道的不良反應(yīng)有惡心,嘔吐,皮疹等?!咀⒁馐马?xiàng)】:孕婦及哺乳期婦女應(yīng)慎用。避免兒童接觸本品。

【禁忌癥】:對本品以及其他喹喏酮類藥物【貯藏】:25℃以下避光保存?!景b】:鋁塑條狀包裝,每條10片。【其它】:【有效期】2年。

【批準(zhǔn)文號】國藥準(zhǔn)字第(00000001)號【生產(chǎn)企業(yè)】浙江省新昌藥業(yè)有限公司《藥學(xué)英語》教學(xué)課件unit8Angised說明書【藥品名稱】:【商品名稱】安吉斯特【通用名稱】硝酸甘油【性狀】:本品為白色扁圓形片劑?!舅幚碜饔谩浚海?)血流量的再分布(2)降低耗氧量(3)降低前負(fù)荷

Angis【適應(yīng)癥】:心絞痛的急性發(fā)作?!窘砂Y】:腦出血或頭部外傷的患者禁用本品?!緞┝亢陀梅ā浚荷嘞潞C咳昼娊o藥一次,每次一片?!静涣挤磻?yīng)】:最常見的不良反應(yīng)是:嘔吐,不安,呼吸受損?!咀⒁馐马?xiàng)】:孕婦及哺乳期婦女應(yīng)慎用。

【適應(yīng)癥】:心絞痛的急性發(fā)作?!举A藏】25℃以下避光保存?!景b】玻璃瓶,不得含有棉絨。【其它】【有效期】3年

【批準(zhǔn)文號】國藥準(zhǔn)字第(00000002)號【生產(chǎn)企業(yè)】浙江省大紅鷹藥業(yè)有限公司《藥學(xué)英語》教學(xué)課件unit8

§11Others

§11Others

一、Thecontentsofothers1、Characteristics:包括藥物的藥理作用特點(diǎn)、療效、劑量及藥物代謝。eg1:①patent:專利(CA.中有專利索引patentindex)②non-narcoticnon—

非--否定詞前綴一、Thecontentsofothers1、ChProperties:eg2:①抗代謝的anti-metabolism②葉酸folicacidFH4四氫葉酸③腫瘤tumor④化療chemotherapy/

放療radiotherapyeg3:①本品毒性小,副作用極為輕微Toxicityislow,Sideeffectsareminimal.②臨床效果:clinicaleffecteg4:①抗炎作用:anti-inflammatoryProperties:Pharmacokinetics:include:metabolism、absorption、distributionandelimination.

*eg7:英漢互譯,要求學(xué)生掌握其中的六個(gè)專業(yè)術(shù)語Theabsolutebioavailabilityofthedrugim.Orsc.Isapproximately70%.Itpeakplasmaconcentrationisattainedwithinonehourandithashalf-lifeofeliminationof70-90minutes.Upto95%ofthedoseisexcretedviathekidneys,2%asunchangeddrug,.Theapparentvolumeofdistributeis0.15-0.31/kgandprotainbinding30-40%.Pharmacokinetics:4overdosage:includetheeffect,signsandsympotoms,treatmentofoverdosage.5interactionordruginteraction詞綴:inter相互eachothereg11:Temariltabletsshouldnotbeadministratedwith4hoursofmedicationscontainingMgnesium,aluminium,orironsaltsasinterferencewithabsorptionmyoccur.eg12:Simultaneousconsumptionofalcoholcanimpairreactiontime,egintrafficorduringreactionofmachines.Athigherdosageofthedrugwithsimultaneousadministrationofbloodpressureloweringmedicamentstheeffectofthelattercanbepotentiated.4overdosage:6ValidityValiditystoragelifeExp.dateshelflifeStableStability:activitytoxicityeg15:Exp:18months(Expirydateisprintedontheviallabel.)6Validity二、otherterms1、參考文獻(xiàn):reference:refer(v.)=literature學(xué)習(xí)書寫論文的一般格式:論文標(biāo)題/摘要/關(guān)鍵詞/參考文獻(xiàn)

title/abstract/keywords/reference2、臨床數(shù)據(jù):clinicaldata=clinicaleffect3、耐受性:tolerance----tolerate

耐藥性:resistance----resistant4、批號:BatchNo.5、制造:madeinmanufacture二、otherterms1、參考文獻(xiàn):reference實(shí)驗(yàn)研究型論文(一)內(nèi)容結(jié)構(gòu)1、中文標(biāo)題2、作者3、中文摘要、關(guān)鍵詞(3—5個(gè))4、正文:

(1)引言

(2)材料與方法

(3)結(jié)果與數(shù)據(jù)處理

(4)討論

(5)結(jié)論

5、參考文獻(xiàn)實(shí)驗(yàn)研究型論文(一)內(nèi)容結(jié)構(gòu)HPLC測定小兒清肺止咳泡騰片中黃芩苷的含量

XXX

(浙江醫(yī)藥高等專科學(xué)校,浙江寧波315100)

摘要:目的:建立一種用高效液相色譜法測定小兒清肺止咳泡騰片中黃芩苷含量的方法。方法:高效液相色譜柱為:DiamonsilC18柱(5μm,250mm×4.6mm);流動相:甲醇-水-甲酸(50︰50︰0.2);檢測波長:280nm;流速:1.2ml/min;結(jié)果:黃芩苷在17.2~172μg/ml的范圍內(nèi)與峰面積呈良好的線性關(guān)系。平均回收率97.97%;RSD為2.18%。結(jié)論:該方法快速,準(zhǔn)確,專屬性好,靈敏度高,可用于小兒清肺止咳泡騰片中黃芩苷的含量測定。關(guān)鍵詞:高效液相色譜法;黃芩苷;小兒清肺止咳泡騰片;含量測定HPLC測定小兒清肺止咳泡騰片中黃芩苷的含量

XXX

(浙DeterminationofBaicalininXiaoerQingfeiZhike

EffervescentTabletbyHPLC

Abstract:Objective:ToestablishacontentdeterminationmethodofbaicalininXiao’erQingfeiZhikeEffervescentTabletbyHPLC.Methods:Results:Conclusion:Keywords:HPLC;Baicalin;XiaoerQingfeiZhikeEffervescentTablet;AssayDeterminationofBaicalinin文獻(xiàn)綜述型畢業(yè)論文1、中文標(biāo)題2、作者3、中文摘要、關(guān)鍵詞(3—5個(gè))4、正文:

(1)引言

(2)正文主要內(nèi)容

(3)展望5、參考文獻(xiàn)文獻(xiàn)綜述型畢業(yè)論文1、中文標(biāo)題三、生產(chǎn)廠家的表示方法:制藥廠:Pharmaceuticalfactory制藥有限公司:pharmaceuticalCO.,Ltd制藥股份有限公司:pharmaceuticalInc.(Incorperator)三、生產(chǎn)廠家的表示方法:制藥廠:Pharmaceutica四、homework按照標(biāo)準(zhǔn)格式,書寫“Aspirin”英文藥品說明書。

ThestructureofEgnlishpackageinsert[Drugname]:[Tradename][Genericname][Chemicalname][Description]:[Pharmacologicalaction]:[Indication]:[Contraindication]:[DosageandAdministration]:[AdverseReaction]:[Precaution]:[Storage]:[Package]:[Others]:[BatchNo.]

[Validity][manufacture]四、homework§1Angised§1Angised[Drugname]:

[tradename]:Angised

(心絞痛Angina)

[genericname]:glyceryltrinitrate

說明:(gly—甘油--yl基團(tuán)

tri—三--ate酸或酯,此處為酯)

[chemicalname]:glyceryltrinitrate[Drugname]:[Description]:

Eachwhite,round,flat,uncoatedtabletsisscoredandimpressed說明:“WellcomP2A”andcontains500microgramsglycerylforsublingualadministration.Analysis:①color:white②shape:roundandflat③preparation:uncoatedandscoredtablet④indigrents:500mgglyceryltrinitrate⑤administration:sl.[Description]:[Pharmacologicalaction]:

①Angisedredistributesbloodflow②Angisedalsoreducedoxygendemand

③ThefallinarterialpressurewillalsoreducemyocardialO2demand.(ItcanreducemyocardialO2demand.)

④Reductionofpreload.

詞綴:pre---dosthbeforeeg.preview預(yù)習(xí)

re---dosthagainoraftereg.review復(fù)習(xí)[Pharmacologicalaction]:[Indication]:(1)acuteattacksofanginapectoris

(2)fortheprophylaxisofsuchattack

(3)pulmonaryoedema[Contra-indication]:

anginacausedbyhypertrophicobstructivecardiomyopathy.

詞綴:myo---肌肉

cerebralhaemorrhageorheadtrauma

詞綴:ha(e)mo---血[Indication]:[DosageandAdministration]:(1)Administration:sublingual

(2)Dosage:

require:Treatmentofacuteattacks①Onetabletshouldbegivenevery3minite.②Theminimumeffectivedose.③Patientsshouldkeepsittingposition《藥學(xué)英語》教學(xué)課件unit8[Adversereaction]:

largedosagemayresultinvomiting,cyanosis,restlessness,impairmentofrespiration,methaemoglobinaemia.[Precaution]:

①②③④⑤[Adversereaction]:[Storage]:

below25℃.Protectfromlight[Package]:

①inglasscontainers②closedwithafoil-linedcap③nocotton-wool[Storage]:[Others]:

[pharmacokinetics]:

1、WhyndoesnotAngisedbetakenbyorally?Glyceryitrinitrateisreadilyabsorbedinthebuccalmucosabutisrapidlymetabolized.ItisalsoreadilyabsorbedinG-Itractbutowingtotheextensivefirst-passmetabolismintheliver.It’sbioavailabilityisreduced.[Others]:2、hydrolysisprocess:

glyceryltrinitrate----glyceryldinitrate----glycerylmononitrate3、metabolismtime:peakplasmalevelappearswithin4minuteatleasthalfoftheintact(untouched、unchanged)drugisclearedfromthebloodin1—3minute.2、hydrolysisprocess:[Druginteraction]:

TherisksofhypotensionandsyncopewithuseofAngisedmaybeebhancedbytheeffectsofalcohol.[Overdosage]:

Methaemoglobinaemiamaybetreatedbyiv.methyleneblue.

(詞綴:methyl---甲基;---ene烯烴)[BatchNo.]:略

[validity]:3years[manufacture]:WellcomFoundationLtdLondon.[Druginteraction]:*§2Temaril

*§2Temaril一、Thebackgroudof“--xacin”

喹啉羧酸類:

①Norfloxacin:85年上市

②Ciprofloxacin:Temaril③Pefloxacin:④Lomefloxacin:⑤Sparfloxacin:⑥Ofloxacin:Terivid一、Thebackgroudof“--xacin”喹TheinformationsaboutCiprofloxacin[Drugname]:

[Tradename]:Temaril[Genericname]:Ciprofloxacin

環(huán)丙沙星

[Chemicalname]:略TheinformationsaboutCiprofl[Description]:

①Infusion:

Temaril:100,clear,almostcolorlesstopaleyellowsilutioncontaining127.2mgCiprofloxacinlactate(equivalentto100mgCiprofloxacin)in50mlsolution.②Tablet:

Temaril:250,white,scored,film-coatedtabletsmarkedononesidewith250,eachtabletscontaining291.5mgCiprofloxacinhydrochloridemonohydrate.Question:WhyCiprofloxacinInfusion---lactateTablet---hydrochloride[Description]:[Pharmacologicalaction]:

①Thedrugisasynthetic(TCM.extract),4-quinolonederivativewithbactericidalactivityagainstawiderangeofG+andG-.(Points:Terms:bactericidalactivity/widerange)②Thedrugisindicatedforthetreatmentofsingleinfectionsormixedinfectionscausedbytwoormoresusceptibleorganisms.(Points:Drill:---beindicatedforthetreatment---)Terms:singleinfectionmixedinfectionsusceptibleorganisms[Pharmacologicalaction]:③Itmaybeusedforinfectionscausedbyorganismsresistanttootherantibiotics,including:amin

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論